Virginia Solitano

34PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Tissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 03, 2026
Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone.

|Jun 30, 2026
Prior exposure to advanced therapy and timing of discontinuation and risk of serious infections in patients with inflammatory bowel disease initiating a new advanced therapy.

|Jun 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trials.

|May 25, 2026
Urinary biomarkers of urolithiasis risk in Crohn's disease: hyperoxaluria, hypocitraturia, and hypomagnesuria in patients with and without ileocolic resection.

|Apr 24, 2026
Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysis.

|Feb 10, 2026
Immunometabolism as a New Bimodal Therapeutic Concept in Inflammatory Bowel Disease and Immune-Mediated Inflammatory Disorders.

Virginia Solitano, Laurent Peyrin-Biroulet, Severine Vermeire

Pageof 6

Frequent Collaborators

13 joint publications

Vipul Jairath

9 joint publications

Christopher Ma

6 joint publications

Silvio Danese

4 joint publications

Neeraj Narula